1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
13 
spection under subsection (a) , the person in charge of the 
place inspected shall provide such samples of — 
( 1 ) recombinant DXA in such place, or 
(2) materials used in or produced by any recom- 
binant DXA activity conducted in such place, 
as the inspector may require to determine if the applicable 
requirements of section 102 are being complied with. 
(c) If during an inspection conducted under subsec- 
tion (a), recombinant DXA or any material used in or 
produced by a recombinant DXA activity which the in- 
spector making the inspection has reason to believe is in- 
volved in a violation of section 103 (a) or presents a sig- 
nificant risk to health or the environment is found in the 
place inspected, such inspector may order the recombinant 
DXA or material detained (in accordance with regulations 
promulgated by the Secretary) for a reasonable period 
which may not exceed twenty days unless the Secretary 
determines that a period of detention greater than twenty 
days is required to institute an action under section 104 (b) , 
in which case the Secretary may authorize a detention pe- 
riod of not to exceed thirty days. Any recombinant DXA 
or material subject to a detention order issued under this 
subsection shall not be moved by any person from the place 
at which it is ordered detained until — 
( 1 ) released by the Secretary, or 
[Appendix B — 233] 
